Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The inhibition of a protein opens the door to the treatment of pancreatic cancer, one of the tumours with the worst prognosis

01.07.2014

The inhibition of a protein opens the door to the treatment of pancreatic cancer, one of the tumours with the worst prognosis

Researchers from IMIM (Hospital del Mar Medical Research Institute) have identified a new protein, galectin-1, as a possible therapeutic target for pancreatic cancer. For the first time they have demonstrated the effects of the inhibition of this protein in mice suffering this type of cancer and the results showed an increase in survival of 20%. The work further suggests that it could be a therapeutic target with no adverse effects.

Until now, the strategies for treating this tumour were aimed at attacking the tumour cells and had little success. The latest studies indicate that trying to destroy what surrounds the tumour is possibly a better strategy. “Our contribution is directed toward this, as the reduction of galectin-1 mainly affects the immune system and the cells and structure that surrounds the tumour cells, which is called the stroma. Therefore, galectin-1 as a therapeutic target has great potential”, explains Dr. Pilar Navarro, co-ordinator of the research group on molecular mechanisms of tumorigenesis of IMIM and director of the research.

It was known that galectin-1 was not found in the normal pancreas despite being strongly expressed in pancreatic tumours. Furthermore, some clear functions were known which demonstrate the relationship between galectin-1 and tumour progression in other contexts. In fact, some preclinical studies for other diseases use inhibitor molecules and antibodies against this protein. “We are aiming at its possible use in pancreatic cancer” states Dr. Neus Martínez, researcher of the group on molecular mechanisms and tumorigenesis of IMIM and first author of this article. “We have also observed that the elimination of galectin-1 in mice has no harmful consequences, indicating that it could be a safe therapeutic target with no adverse effects”, she adds.

In collaboration with the Hospital del Mar Anatomical Pathology Service, which has analysed some samples, pancreatic tumours were studied in mice with high levels of galectin-1 and after its depletion. They observed that tumours without this protein showed less proliferation, fewer blood vessels, less inflammation and an increase in the immune response. All these changes are associated with less aggressive tumours.

Pancreatic cancer is one of the tumours with the worst prognosis, with a survival rate of less than 2%, 5 years after diagnosis. Although it is not a very common tumour, it is the fourth cause of cancer-related death in developed countries. This is due, on one hand, to the fact that it is often diagnosed too late, when the tumour has already metastasised and, on the other hand, to the inefficacy of current treatments. In Spain 4000 cases are diagnosed each year. Although it is a tumour that is well known at molecular level, its diagnosis and treatment are still one step behind. In fact it is one of the tumours with the least therapeutic advancements in recent years.

The results are very encouraging but we must be prudent as there are many factors to take into account. The researchers now want to move the results obtained to preclinical studies, where they will treat mice with pancreatic cancer with chemical inhibitors or antibodies against galectin-1 (the same treatment that would be used for a cancer patient) in order to verify the therapeutic utility of this target. In the event that they obtain positive results and manage to halt the tumour, the next step would be to propose its use on patients. Obviously we are talking about long-term objectives, as the transfer of studies on animals to humans is usually a slow process.

Reference article:

Galectin-1 drives pancreatic carcinogenesis through stroma remodeling and Hedgehog signaling activation. Neus Martinez-Bosch, Maite G Fernandez-Barrena, Mireia Moreno, Elena Ortiz-Zapater, Jessica Munné-Collado, Mar Iglesias, Sabine André, Hans-Joachim Gabius, Rosa F. Hwang, Françoise Poirier, Carolina Navas, Carmen Guerra, Martin E. Fernández-Zapico, and Pilar Navarro. Cancer Res. Doi:10.1158/0008-5472.CAN-13-3013

Marta Calsina | Eurek Alert!
Further information:
http://www.imim.es/news/184/the-inhibition-of-a-protein-opens-the-door-to-the-treatment-of-pancreatic-cancer-one-of-the-tumours-with-the-worst-prognosis

More articles from Life Sciences:

nachricht Stick insects produce bacterial enzymes themselves
31.05.2016 | Max-Planck-Institut für chemische Ökologie

nachricht New Model of T Cell Activation
27.05.2016 | Albert-Ludwigs-Universität Freiburg im Breisgau

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attosecond camera for nanostructures

Physicists of the Laboratory for Attosecond Physics at the Max Planck Institute of Quantum Optics and the Ludwig-Maximilians-Universität Munich in collaboration with scientists from the Friedrich-Alexander-Universität Erlangen-Nürnberg have observed a light-matter phenomenon in nano-optics, which lasts only attoseconds.

The interaction between light and matter is of key importance in nature, the most prominent example being photosynthesis. Light-matter interactions have also...

Im Focus: Worldwide Success of Tyrolean Wastewater Treatment Technology

A biological and energy-efficient process, developed and patented by the University of Innsbruck, converts nitrogen compounds in wastewater treatment facilities into harmless atmospheric nitrogen gas. This innovative technology is now being refined and marketed jointly with the United States’ DC Water and Sewer Authority (DC Water). The largest DEMON®-system in a wastewater treatment plant is currently being built in Washington, DC.

The DEMON®-system was developed and patented by the University of Innsbruck 11 years ago. Today this successful technology has been implemented in about 70...

Im Focus: Computational high-throughput screening finds hard magnets containing less rare earth elements

Permanent magnets are very important for technologies of the future like electromobility and renewable energy, and rare earth elements (REE) are necessary for their manufacture. The Fraunhofer Institute for Mechanics of Materials IWM in Freiburg, Germany, has now succeeded in identifying promising approaches and materials for new permanent magnets through use of an in-house simulation process based on high-throughput screening (HTS). The team was able to improve magnetic properties this way and at the same time replaced REE with elements that are less expensive and readily available. The results were published in the online technical journal “Scientific Reports”.

The starting point for IWM researchers Wolfgang Körner, Georg Krugel, and Christian Elsässer was a neodymium-iron-nitrogen compound based on a type of...

Im Focus: Atomic precision: technologies for the next-but-one generation of microchips

In the Beyond EUV project, the Fraunhofer Institutes for Laser Technology ILT in Aachen and for Applied Optics and Precision Engineering IOF in Jena are developing key technologies for the manufacture of a new generation of microchips using EUV radiation at a wavelength of 6.7 nm. The resulting structures are barely thicker than single atoms, and they make it possible to produce extremely integrated circuits for such items as wearables or mind-controlled prosthetic limbs.

In 1965 Gordon Moore formulated the law that came to be named after him, which states that the complexity of integrated circuits doubles every one to two...

Im Focus: Researchers demonstrate size quantization of Dirac fermions in graphene

Characterization of high-quality material reveals important details relevant to next generation nanoelectronic devices

Quantum mechanics is the field of physics governing the behavior of things on atomic scales, where things work very differently from our everyday world.

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Networking 4.0: International Laser Technology Congress AKL’16 Shows New Ways of Cooperations

24.05.2016 | Event News

Challenges of rural labor markets

20.05.2016 | Event News

International expert meeting “Health Business Connect” in France

19.05.2016 | Event News

 
Latest News

Better combustion for power generation

31.05.2016 | Power and Electrical Engineering

Stick insects produce bacterial enzymes themselves

31.05.2016 | Life Sciences

In a New Method for Searching Image Databases, a Hand-drawn Sketch Is all it Takes

31.05.2016 | Information Technology

VideoLinks
B2B-VideoLinks
More VideoLinks >>>